Soler D, Chapman T, Yang LL, Wyant T, Egan R, Fedyk ER «The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases». J. Pharmacol. Exp. Ther., 330, 3, 9-2009, pàg. 864–75. DOI: 10.1124/jpet.109.153973. PMID: 19509315.
nih.gov
ncbi.nlm.nih.gov
Soler D, Chapman T, Yang LL, Wyant T, Egan R, Fedyk ER «The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases». J. Pharmacol. Exp. Ther., 330, 3, 9-2009, pàg. 864–75. DOI: 10.1124/jpet.109.153973. PMID: 19509315.